Chemoinformaics analysis of [(1-Butylnonyl)oxy](isopropyl)dimethylsilane
| Molecular Weight | 222.372 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 10 |
| Exact Molecular Weight | 222.198 | nRing | 1 |
| Solubility: LogS | -5.166 | nHRing | 0 |
| Solubility: LogP | 3.977 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.663 |
| Synth | 4.22 |
| Natural Product Likeliness | 3.494 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.008 |
| HIA | 0.081 |
| CACO-2 | -4.44 |
| MDCK | 0.000023 |
| BBB | 0.551 |
| PPB | 0.921796 |
| VDSS | 2.157 |
| FU | 0.0267958 |
| CYP1A2-inh | 0.143 |
| CYP1A2-sub | 0.707 |
| CYP2c19-inh | 0.403 |
| CYP2c19-sub | 0.881 |
| CYP2c9-inh | 0.344 |
| CYP2c9-sub | 0.852 |
| CYP2d6-inh | 0.214 |
| CYP2d6-sub | 0.233 |
| CYP3a4-inh | 0.759 |
| CYP3a4-sub | 0.431 |
| CL | 4.883 |
| T12 | 0.329 |
| hERG | 0.024 |
| Ames | 0.004 |
| ROA | 0.03 |
| SkinSen | 0.715 |
| Carcinogencity | 0.053 |
| EI | 0.85 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.821984 |